Crescent Biopharma, Inc.
CBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001253689
In the last 90 days, Crescent Biopharma, Inc. insiders filed 1 open-market purchase and 7 sales; 82 institutions reported holding it in 13F filings for Q2 2026, worth $532.6M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Crescent Biopharma, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 36
- +2 vs. Q2 2024
- Shares held
- 17.8M
- −7.05M (−28.4%) vs. Q2 2024
- Total value
- $3.00M
- −$3.99M (−57.1%) vs. Q2 2024
- New holders
- 12
- 3 more added
- Sold out
- 10
- 12 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CBIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 82 | $532.6M |
| Q1 2026 | 63 | $476.6M |
| Q4 2025 | 58 | $285.9M |
| Q3 2025 | 41 | $134.6M |
| Q2 2025 | 30 | $173.5M |
| Q1 2025 | 35 | $6.46M |
| Q4 2024 | 41 | $7.56M |
| Q3 2024 | 36 | $3.00M |
| Q2 2024 | 35 | $7.20M |
| Q1 2024 | 69 | $110.5M |
| Q4 2023 | 58 | $82.8M |
| Q3 2023 | 49 | $52.1M |
| Q2 2023 | 55 | $61.9M |
| Q1 2023 | 54 | $46.6M |
| Q4 2022 | 48 | $83.3M |
| Q3 2022 | 35 | $14.3M |
| Q2 2022 | 37 | $15.8M |
| Q1 2022 | 44 | $31.2M |
| Q4 2021 | 47 | $42.7M |
| Q3 2021 | 48 | $64.9M |
| Q2 2021 | 58 | $72.5M |
| Q1 2021 | 78 | $110.4M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Crescent Biopharma, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 2,000 | $0 | 0.00% | −319−13.8% | Reduced |
| Barclays PLC | 76 | $13 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 141 | $24 | 0.00% | −10−6.6% | Reduced |
| Bank of America Corp | 464 | $78 | 0.00% | −4,938−91.4% | Reduced |
| BNP Paribas Arbitrage, SA | 481 | $81 | 0.00% | 00.0% | Unchanged |
| Truvestments Capital LLC | 1,309 | $221 | 0.00% | +1,309 | New |
| EverSource Wealth Advisors, LLC | 4,755 | $804 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 5,176 | $874 | 0.00% | 00.0% | Unchanged |
| Baader Bank INC | 10,672 | $1.29K | 0.00% | +10,672 | New |
| Jump Financial, LLC | 11,506 | $1.95K | 0.00% | +11,506 | New |
| Pine Valley Investments Ltd Liability Co | 12,520 | $2.12K | 0.00% | +12,520 | New |
| Tobias Financial Advisors, Inc. | 15,000 | $2.54K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 19,542 | $3.00K | 0.00% | +19,542 | New |
| Millennium Management LLC | 18,865 | $3.19K | 0.00% | −167,362−89.9% | Reduced |
| Two Sigma Securities, LLC | 22,158 | $3.75K | 0.00% | +22,158 | New |
| XTX Topco Ltd | 24,929 | $4.21K | 0.00% | +24,929 | New |
| HRT Financial LP | 32,324 | $5.00K | 0.00% | −15,359−32.2% | Reduced |
| LPL Financial LLC | 30,700 | $5.19K | 0.00% | +1,700+5.9% | Added |
| Group One Trading, L.P. | 38,017 | $6.42K | 0.00% | −27,416−41.9% | Reduced |
| Ieq Capital, LLC | 38,363 | $6.48K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 44,646 | $7.54K | 0.00% | +44,646 | New |
| ADAR1 Capital Management, LLC | 45,700 | $7.72K | 0.00% | −89,300−66.1% | Reduced |
| Intellectus Partners, LLC | 45,965 | $7.77K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 68,440 | $11.6K | 0.00% | −14,580−17.6% | Reduced |
| Gsa Capital Partners LLP | 83,725 | $14.0K | 0.00% | +83,725 | New |
| HCR Wealth Advisors | 100,000 | $16.9K | 0.00% | +100,000 | New |
| Northern Trust Corp | 116,985 | $19.8K | 0.00% | −10,807−8.5% | Reduced |
| State Street Corp | 179,265 | $30.3K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 248,958 | $42.1K | 0.00% | +140,158+128.8% | Added |
| Acadian Asset Management LLC | 357,439 | $59.0K | 0.00% | −177,314−33.2% | Reduced |
| Geode Capital Management, LLC | 521,223 | $88.1K | 0.00% | +33,981+7.0% | Added |
| BlackRock, Inc. | 727,858 | $123.0K | 0.00% | +727,858 | New |
| Renaissance Technologies LLC | 781,100 | $132.0K | 0.00% | −45,751−5.5% | Reduced |
| Siren, L.L.C. | 1,965,114 | $332.1K | 0.02% | +1,965,114 | New |
| Vanguard Group Inc | 2,670,208 | $451.3K | 0.00% | −26,698−1.0% | Reduced |
| BVF Inc | 9,544,262 | $1.61M | 0.05% | 00.0% | Unchanged |
| Artal Group S.A. | 0 | $0 | 0.00% | −8,589,064−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −804,342−100.0% | Sold out |
| Sargent Investment Group, LLC | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −81,800−100.0% | Sold out |
| Letko, Brosseau & Associates Inc | 0 | $0 | 0.00% | −45,250−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −29,697−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −14,102−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −1,101−100.0% | Sold out |
| Rhumbline Advisers | 0 | $0 | 0.00% | −1,044−100.0% | Sold out |
| National Bank of Canada | 0 | $0 | 0.00% | −600−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |